Arrowhead Pharmaceuticals: Q3 Earnings Insights

Arrowhead Pharmaceuticals ARWR reported its Q3 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Arrowhead Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.68 versus an estimate of $-0.51.

Revenue was down $13.48 million from the same period last year.

Last quarter the company beat on EPS by $0.49 which was followed by a 15.57% drop in the share price the next day.

Here's a look at Arrowhead Pharmaceuticals's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.08	-0.45	-0.10	-0.20
EPS Actual	0.41	-0.60	-0.61	-0.29
Revenue Estimate	108.91M	51.04M	56.77M	37.52M
Revenue Actual	151.81M	27.44M	38.28M	45.89M

To track all earnings releases for Arrowhead Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar